Edwards BioPhysio Valve To Solve Stentless Versus Stented Conundrum
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences will begin clinical trials this year for its BioPhysio replacement heart valve technology, combining the advantages of the company's stented and stentless tissue replacement valves